FBO Notice Date 11/16/17
BIDS Reference Number 77
Document Type: Presolicitation
Medical, Dental & Veterinary Equipment & Supplies

Department of Veterans Affairs, VA National Acquisition Center, Department of Veterans Affairs National Acquisition Center, 60141

65 -- Labetolol Tablets (VA-18-919316) SOL 36E79718R0011 DUE 121917Richard MaharioContract Specialist708-786-5247Page 1 of 1PRE-SOLICITATION NOTICE:  The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79718R0011 for an unrestricted procurement for Labetalol Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS).  Award willbe made to the responsible contractor(s) per individual product group or a combination of product groups if this results in the lowest overall price to the Government. To be considered for award, offerors must propose prices for all line items for the base and each option year for all items within a product group or groups proposed. Line items 1, 2, 3, 4, and 5. The period of contract will be for one year plus four one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Solicitation # 36E79718R0011 will be electronically issued in commercial itemformat in accordance with FAR Part 12 on or about December 4, 2017, with a tentative closing date of December 19, 2017.  The NAICS code for this procurement is 325412.  Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov.  No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted.   Interested offerors are advised to continuously check this URL for any changes to this solicitation.  Offers will be considered technically acceptable if the meet the following criteria: 1) NDC must be unique to the offeror, 2) Drug must be FDA approved,3) Manufacturing facility must have an acceptable current Good Manufacturing Practices rating by FDA. 4) Offeror must meet the estimated annual requirements aslisted below.  All responsible sources may submit an offer that if timely received, will be considered.  The point of contact for this procurement is RichardMahario.  Questions can be e-mailed to: Richard.Mahario@va.gov  The estimated annual requirements are as follows:Description       Size   Estimated Annual Requirements

Labetalol HCL 100MG Bottles of 100 Tablets 26,864

Labetalol HCL 100MG Bottles of 500 Tablets 2,785

Labetalol HCL 200MG Bottles of 100 Tablets 19,889

Labetalol HCL 200MG Bottles of 500 Tablets 9,681

Labetalol HCL 300MG Bottles of 100 Tablets 20,544

CITE: https://www.fbo.gov/spg/VA/VANAC/VANAC/36E79718R0011/listing.html